Better Therapeutics, Inc.
DelistedCIK 1832415fmd_1311Z56W8MAMV734FKSAM0SSYVServices · Services-Health ServicesTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 12 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 0 | – | – |
| Research and development | 4 | 19 | 16 |
| Selling, general and administrative | 3 | 11 | 22 |
| Total operating expenses | 6 | 31 | 38 |
| Operating income | (6) | (31) | (38) |
| Interest expense | 0 | 0 | 1 |
| Income before taxes | (6) | (40) | (40) |
| Income tax expense | 0 | (0) | 0 |
| Net income from continuing operations | (6) | (40) | (40) |
| Net income | (6) | (40) | (40) |
| Net income to common shareholders | (8) | (40) | – |